Donald J. Hayden Jr. - 17 May 2022 Form 3 Insider Report for Theseus Pharmaceuticals, Inc.

Role: Director
Signature: /s/ Bradford Dahms - Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 17 May 2022
Net transactions value: $0
Form type: 3
Filing time: 18 May 2022, 16:24:32 UTC
Next filing: 03 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney